ABA Chemicals Past Earnings Performance
Past criteria checks 0/6
ABA Chemicals's earnings have been declining at an average annual rate of -31.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 7.6% per year.
Key information
-31.2%
Earnings growth rate
-31.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -7.6% |
| Return on equity | -8.8% |
| Net Margin | -19.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How ABA Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,118 | -216 | 158 | 105 |
| 30 Jun 24 | 1,016 | -231 | 201 | 97 |
| 31 Mar 24 | 1,020 | -181 | 214 | 109 |
| 31 Dec 23 | 1,279 | -82 | 217 | 118 |
| 30 Sep 23 | 1,501 | 98 | 231 | 127 |
| 30 Jun 23 | 1,756 | 169 | 220 | 134 |
| 31 Mar 23 | 1,934 | 186 | 212 | 133 |
| 01 Jan 23 | 2,001 | 203 | 206 | 130 |
| 30 Sep 22 | 2,068 | 213 | 221 | 120 |
| 30 Jun 22 | 2,011 | 208 | 201 | 116 |
| 31 Mar 22 | 2,087 | 201 | 201 | 124 |
| 01 Jan 22 | 2,072 | 182 | 203 | 123 |
| 30 Sep 21 | 2,109 | 189 | 186 | 125 |
| 30 Jun 21 | 2,236 | 175 | 176 | 134 |
| 31 Mar 21 | 2,064 | 155 | 168 | 117 |
| 31 Dec 20 | 2,003 | 161 | 157 | 117 |
| 30 Sep 20 | 2,062 | 154 | 182 | 121 |
| 30 Jun 20 | 1,899 | 165 | 177 | 111 |
| 31 Mar 20 | 1,648 | 90 | 162 | 105 |
| 31 Dec 19 | 1,664 | 82 | 162 | 105 |
| 30 Sep 19 | 1,592 | 91 | 123 | 101 |
| 30 Jun 19 | 1,598 | 91 | 129 | 97 |
| 31 Mar 19 | 1,798 | 172 | 175 | 118 |
| 31 Dec 18 | 1,806 | 161 | 162 | 106 |
| 30 Sep 18 | 1,660 | 143 | 104 | 148 |
| 30 Jun 18 | 1,566 | 108 | 116 | 128 |
| 31 Mar 18 | 1,458 | 93 | 84 | 92 |
| 31 Dec 17 | 1,208 | 73 | 102 | 79 |
| 30 Sep 17 | 1,049 | 45 | 172 | 0 |
| 30 Jun 17 | 915 | 45 | 159 | 0 |
| 31 Mar 17 | 786 | 23 | 155 | 0 |
| 31 Dec 16 | 662 | 16 | 150 | 0 |
| 30 Sep 16 | 641 | 35 | 143 | 0 |
| 30 Jun 16 | 590 | 36 | 135 | 0 |
| 31 Mar 16 | 572 | 56 | 121 | 0 |
| 31 Dec 15 | 627 | 61 | 118 | 0 |
| 30 Sep 15 | 595 | 64 | 107 | 0 |
| 30 Jun 15 | 573 | 59 | 100 | 0 |
| 31 Mar 15 | 586 | 55 | 97 | 0 |
| 31 Dec 14 | 526 | 51 | 83 | 0 |
| 30 Sep 14 | 511 | 46 | 76 | 0 |
| 30 Jun 14 | 498 | 46 | 70 | 0 |
| 31 Mar 14 | 429 | 41 | 63 | 0 |
| 31 Dec 13 | 411 | 44 | 59 | 0 |
Quality Earnings: 300261 is currently unprofitable.
Growing Profit Margin: 300261 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300261 is unprofitable, and losses have increased over the past 5 years at a rate of 31.2% per year.
Accelerating Growth: Unable to compare 300261's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300261 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 300261 has a negative Return on Equity (-8.84%), as it is currently unprofitable.